Brief: Hofseth Biocare Q2 EBITDA Loss NOK 17.3 Million

Hofseth Biocare ASA

28/08/2020 07:17

Aug 28 (Reuters) - Hofseth Biocare ASA  HOFS.OL :
    * REG-HOFSETH BIOCARE ASA: SECOND QUARTER & HALF YEAR 2020
FINANCIAL REPORT
    * OPERATING REVENUES OF NOK 20.0 MILLION IN Q2 OF 2020, AN
INCREASE OF 57 PERCENT COMPARED TO SIMILAR PERIOD LAST YEAR.
    * Q2 OPERATING PROFIT (EBITDA) IN Q2 WAS NEGATIVE NOK 17.3
MILLION
(8.3 MILLION)

Source text for Eikon:  ID:nGNE8rbcwK 
Further company coverage:  HOFS.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))